| Schedule of Reconciliation of the Weighted Average Number of Common Shares Outstanding used in Calculating Basic and Diluted Net Loss Per Share |
The
following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss
per share (in thousands):
Schedule
of Reconciliation of the Weighted Average Number of Common Shares Outstanding used in Calculating Basic and Diluted Net Loss
Per Share
| |
|
June
30, 2026 |
|
|
June
30, 2025 |
|
|
June
30, 2026 |
|
|
June
30, 2025 |
|
| |
|
For
the three months ended |
|
|
For
the six months ended |
|
| |
|
June
30, 2026 |
|
|
June
30, 2025 |
|
|
June
30, 2026 |
|
|
June
30, 2025 |
|
| Loss from continuing
operations after income taxes |
|
$ |
(3,051 |
) |
|
$ |
(4,472 |
) |
|
$ |
(8,226 |
) |
|
$ |
(9,150 |
) |
| Income
from discontinued operations, net of tax |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
8,644 |
|
| Net
loss |
|
$ |
(3,051 |
) |
|
$ |
(4,472 |
) |
|
$ |
(8,226 |
) |
|
$ |
(506 |
) |
| Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
14,016 |
|
|
|
4,154 |
|
|
|
13,171 |
|
|
|
3,840 |
|
| Diluted |
|
|
14,016 |
|
|
|
4,154 |
|
|
|
13,171 |
|
|
|
3,840 |
|
| Net earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss
from continuing operations, basic and diluted |
|
$ |
(0.22 |
) |
|
$ |
(1.08 |
) |
|
$ |
(0.62 |
) |
|
$ |
(2.38 |
) |
| Income
from discontinued operations, basic and diluted |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
2.25 |
|
| Net
loss (earnings) per share, basic and diluted |
|
$ |
(0.22 |
) |
|
$ |
(1.08 |
) |
|
$ |
(0.62 |
) |
|
$ |
(0.13 |
) |
|
| Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation |
The
following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive
effect (in thousands):
Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation
| Anti-dilutive securities |
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
| |
|
For the three months ended |
|
|
For the six months ended |
|
| Anti-dilutive securities |
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
| Common stock purchase warrants |
|
|
997 |
|
|
|
174 |
|
|
|
997 |
|
|
|
174 |
|
| Stock options |
|
|
478 |
|
|
|
445 |
|
|
|
478 |
|
|
|
445 |
|
| Convertible notes |
|
|
13,773 |
|
|
|
- |
|
|
|
13,773 |
|
|
|
- |
|
| Anti-dilutive securities |
|
|
15,248 |
|
|
|
619 |
|
|
|
15,248 |
|
|
|
619 |
|
|